Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Garmo

Showing results (151-160 of 261) with videos related to

Pageof 27
Sort By:
Scandinavian Journal of Urology|August 1, 2020
PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testingAnna Pia Enblad, Oskar Bergengren, Ove Andrén, et al.
BMC Cancer|April 6, 2017
Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohortJennifer C Melvin, Hans Garmo, Lars Holmberg, et al.
Acta Oncologica (Stockholm, Sweden)|February 19, 2021
Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in SwedenGincy George, Hanna Vikman, Rolf Gedeborg, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2011
Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancerAnders Berglund, Hans Garmo, David Robinson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 8, 2017
The use of palliative medications before death from prostate cancer: Swedish population-based study with a comparative overview of European dataMagdalena Lycken, Linda Drevin, Hans Garmo, et al.
Prostate Cancer and Prostatic Diseases|March 4, 2020
Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control studyKerri Beckmann, Hans Garmo, Bertil Lindahl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 22, 2016
Inter-observer variation in delineating the coronary arteries as organs at riskAnna-Karin Wennstig, Hans Garmo, Per Hållström, et al.
European Urology|October 2, 2012
Thromboembolic events following surgery for prostate cancerMieke Van Hemelrijck, Hans Garmo, Lars Holmberg, et al.
Breast (Edinburgh, Scotland)|July 15, 2021
Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort studyMaria Sund, Miguel Garcia-Argibay, Hans Garmo, et al.
Cancer Causes & Control : CCC|December 11, 2008
Season of diagnosis and prognosis in breast and prostate cancerLars Holmberg, Jan Adolfsson, Lorelei Mucci, et al.
Pageof 27

Showing results (151-160 of 261) with videos related to

Sort By:
Pageof 27
Scandinavian Journal of Urology|August 1, 2020
PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testingAnna Pia Enblad, Oskar Bergengren, Ove Andrén, et al.
BMC Cancer|April 6, 2017
Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohortJennifer C Melvin, Hans Garmo, Lars Holmberg, et al.
Acta Oncologica (Stockholm, Sweden)|February 19, 2021
Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in SwedenGincy George, Hanna Vikman, Rolf Gedeborg, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2011
Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancerAnders Berglund, Hans Garmo, David Robinson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 8, 2017
The use of palliative medications before death from prostate cancer: Swedish population-based study with a comparative overview of European dataMagdalena Lycken, Linda Drevin, Hans Garmo, et al.
Prostate Cancer and Prostatic Diseases|March 4, 2020
Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control studyKerri Beckmann, Hans Garmo, Bertil Lindahl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 22, 2016
Inter-observer variation in delineating the coronary arteries as organs at riskAnna-Karin Wennstig, Hans Garmo, Per Hållström, et al.
European Urology|October 2, 2012
Thromboembolic events following surgery for prostate cancerMieke Van Hemelrijck, Hans Garmo, Lars Holmberg, et al.
Breast (Edinburgh, Scotland)|July 15, 2021
Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort studyMaria Sund, Miguel Garcia-Argibay, Hans Garmo, et al.
Cancer Causes & Control : CCC|December 11, 2008
Season of diagnosis and prognosis in breast and prostate cancerLars Holmberg, Jan Adolfsson, Lorelei Mucci, et al.
Pageof 27